Accelerate Diagnostics Inc

NASDAQ: AXDX    
Share price (5/3/24): $0.94    
Market cap (5/3/24): $20.4 million
Search in Documents
Key Exhibits
External Links
3 Accelerate Diagnostics Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.30
from 10-K 14 pages Material contract
12/34/56
EX-10.17
from 10-K 9 pages Attachment B Consulting Services Agreement
12/34/56
EX-10.1
from 8-K 23 pages Form of Subscription Agreement
12/34/56
EX-10.3
from 8-K 3 pages First Amendment to Note Exchange Agreement
12/34/56
EX-10.2
from 8-K 3 pages First Amendment to Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages First Amendment to Securities Purchase Agreement Accelerate Diagnostics, Inc. and Jack W. Schuler Living Trust
12/34/56
EX-10.8
from 8-K 12 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 8-K 19 pages Amendment No. 1 to Securities Purchase Agreement
12/34/56
EX-10.6
from 8-K 4 pages Consent and Amendment No. 1 to Secured Promissory Note
12/34/56
EX-10.3
from 8-K 59 pages Security Agreement Among Accelerate Diagnostics, Inc., as Issuer, and the Guarantors Party Hereto From Time to Time, as Guarantors and U.S. Bank Trust Company, National Association, as Collateral Agent Dated as of June 9, 2023
12/34/56
EX-10.2
from 8-K 35 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 44 pages Note Exchange Agreement
12/34/56
EX-10.1
from 8-K 1 page First Amendment to the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan
12/34/56
EX-10.3
from 10-Q 13 pages March 9, 2023 David Patience Delivered Electronically via Email Re: Change in Employment Status
12/34/56
EX-10.1
from 8-K 63 pages [***] Portions of This Exhibit Have Been Redacted Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 8-K 19 pages Forbearance Agreement
12/34/56
EX-10.1
from 8-K 5 pages Separation Agreement and Release
12/34/56
EX-10.5
from 10-Q 44 pages Sales and Marketing Agreement
12/34/56
EX-10.4
from 8-K 13 pages Security Agreement
12/34/56
EX-10.3
from 8-K 9 pages Accelerate Diagnostics, Inc. Warrant to Purchase Common Stock
12/34/56